Amyotrophic lateral sclerosis & frontotemporal degeneration · 2020
Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Vasta Rosario, Moglia Cristina, D'Ovidio Fabrizio, Di Pede Francesca, De Mattei Filippo, Cabras Sara, Peotta Laura, Iazzolino Barbara, Giusiano Silvia, Manera Umberto, Palumbo Francesca, Bombaci Alessandro, Torrieri Maria Claudia, Ilardi Antonio, Mastro Enza, Arcari Martina, Solero Luca, Grassano Maurizio, Daviddi Margherita, Matteoni Enrico, Salamone Paolina, Fuda Giuseppe, Canosa Antonio, Chiò Adriano, Calvo Andrea
Аннотация
We describe the telemedicine experience of an Italian ALS tertiary Center during COVID-19 pandemic. A total of 144 visits were scheduled between 6th March and 6th April 2020. These mostly consisted of neurological or psychological visits (139, 96.5%). One hundred thirty-nine (96.5%) visits were performed as telemedicine and mostly via phone call (112, 80.6%). Three (2.1%) visits were considered as urgent and maintained as outpatient care. Additionally, patients were still able to telephone, being put through directly to their neurologists. Many requests of contact were addressed at getting information about the scheduled visits or examinations (45, 43.3%). Globally, patients and caregivers were satisfied with the telemedicine service. However, the majority (85, 65.9%) would prefer a face-to-face visit. In conclusion, telemedicine could be considered a good complement to face-to-face care, even after social restrictions have been eased.